Rostislav Zatonsky/Alamy
Women are not simply “smaller men.” For many years, medical research has primarily focused on male rodents, which lack the intricate hormonal cycles found in females, subsequently applying these findings to women as if they were the same. Fortunately, recent decades have seen a growing understanding that this oversight is detrimental to women’s health, often leading to treatments that are less effective for them than for men.
Recent studies on how sex chromosomes influence immune systems reveal another layer to this narrative. Overlooking the intricacies of women’s bodies impacts everyone, not solely women (see “Women’s Immune Systems Are Stronger – Now We Know Why”).
A significant part of the issue arises from averaging effects. While statistical methods can help clarify fluctuations and unveil impactful insights, excessive reliance on them can obscure critical signals. Women generally possess more robust and responsive immune systems compared to the average man, showing longer-lasting responses to vaccines and a lower likelihood of mortality from infections in older age.
“
Neglecting the complexity of women’s bodies affects everyone, not just women.
“
However, by combining male and female participants in medical research trials, distinct sex differences in reactions to antiviral medications and vaccines, although better than excluding women entirely, may still be obscured. This could result in men receiving inadequate dosages for effective treatment and women receiving excessive amounts. Furthermore, minimal attention has been given to how these differences impact transgender individuals.
Ultimately, researchers are uncovering how the X chromosome and hormones contribute to these sex-based differences. Insights from this research should help in refining treatments for a variety of conditions, from long COVID-19 to cancer, benefiting everyone. Embracing the complexity of our bodies rather than viewing women as “smaller men” is crucial.
Source: www.newscientist.com
